Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This was posted on the Yahoo board--

maybe , but my guess is that they have some left just that they're below reporting levels.

But whatever they have it is still a supply and demand issue with PTSC..... way too many shares with little or no interest on the buy side...PTO validation will get us a little spurt but even with continued license signings, as long as we, the current owners, the public watching in on us along with probably some small funds....without any numbers being attrached to these signings there will be little or no movement.

Most will wait to see what kind of effect they have on the Q and of course many are waiting to see what impact, positive or negative, our CEO has embarked us on with the new ventures, before they jump in.

Share
New Message
Please login to post a reply